MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/rhu.0000000000001969

Медицинская библиотека · Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2023

Risk Factors for Relapse and/or Prolonged Glucocorticoid Therapy in Polymyalgia Rheumatica: Multicenter Study in 185 Patients.

Vinicki Juan Pablo, Gut Oscar, Maliandi María Del Rosario, Velasco Zamora Jose Luis, Linarez Miguel, Cusa Maria Alejandra, Got Julio, Spinetto Maria Andrea, Estevez Adrian Jorge, Brigante Alejandro, Curti Ana Carolina, Costi Ana Carolina, Cavallasca Javier

Наблюдательное исследованиеМногоцентровое исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND

In polymyalgia rheumatica (PMR) relapses and long-term GC dependency are common. We assessed risk factors for higher relapse rate and/or prolonged glucocorticoid therapy in PMR patients.

METHODS

A multicenter and observational study (chart review) of PMR patients seen between 2006 and 2021 who had at least a 3-month follow-up period after starting GCs was performed. Results were expressed as median and interquartile range 25th-75th or mean ± standard deviation for numerical variables and percentage for categorical ones. Relapse versus nonrelapse groups were compared using Cox proportional analysis. Hazards ratios (HRs) with 95% confidence intervals (CIs) are reported. In all cases, a p value <0.05 was considered to indicate statistical significance.

RESULTS

We included 185 patients (69.1% female). The median follow-up time was 17.1 months (interquartile range, 6.8-34.7). Incidence of relapses was 1.2 per 100 persons/month. In univariate analysis, PMR patients with a previous history of dyslipidemia had a lower risk of relapse (HR, 0.55; 95% CI, 0.33-0.94; p = 0.03); high-dose GC (HR, 2.35; 95% CI, 1.42-3.87; p = 0.001) and faster GC dose reduction had higher risk of relapse (HR, 3.04; 95% CI, 1.77-5.21; p = 0.001). In multivariate analysis, a previous history of dyslipidemia had a lower risk of relapse (HR, 0.54; 95% CI, 0.32-0.92; p = 0.023), and high dose of GC (HR, 2.46; 95% CI, 1.49-4.08; p = 0.001) remained the only risk factors for relapse.

CONCLUSIONS

Lower doses of corticosteroids and a slow rate of reduction are critical to avoid relapse in PMR. Risk factors for higher relapse rate rely on therapy more than clinical characteristics of the patients at the time of diagnosis of PMR.

Для цитирования: Vinicki Juan Pablo, Gut Oscar, Maliandi María Del Rosario, Velasco Zamora Jose Luis, Linarez Miguel, Cusa Maria Alejandra, Got Julio, Spinetto Maria Andrea, Estevez Adrian Jorge, Brigante Alejandro, Curti Ana Carolina, Costi Ana Carolina, Cavallasca Javier. Risk Factors for Relapse and/or Prolonged Glucocorticoid Therapy in Polymyalgia Rheumatica: Multicenter Study in 185 Patients.. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2023. DOI: 10.1097/rhu.0000000000001969.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.